Although it has been reported that both miR-30a and SOX4 are involved in regulation of EMT and stemness, we are the first to report that miR-30a targets SOX4 to inhibit EMT and CSC phenotypes in breast cancer through TGF-β/SMAD pathway. The gene discussed is SOX4; the disease is breast cancer.